 |
|
Changes in Morbidity After Pancreatic Resection—Invited Critique
Yuman Fong, MD
New York, NY
Arch Surg. 2003;138:1315.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The past 2 decades have seen tremendous improvements and refinements in pancreatic resections. The article in this issue of the ARCHIVES by Büchler and colleagues is a remarkable documentation of 617 pancreatectomies performed by a single group and echoes the results currently seen in many major centers. The pancreatoduodenectomy is now performed in a few hours at most major hospitals, with operative mortalities less than 4% and with most patients returning to normal function. Because pancreatectomy represents the only curative therapy for pancreatic adenocarcinoma, improvement in perioperative outcome is a first step toward effective treatment of this disease. However, the long-term outcome for pancreatic adenocarcinoma is still extremely poor. The actuarial 5-year survival in most major series is less than 20%, and even at major centers, there are few actual 5-year, disease-free survivors.1-3 Thus, the surgical procedure has prolonged survival but has had little effect on long-term . . . [Full Text of this Article]
RELATED ARTICLE
Changes in Morbidity After Pancreatic Resection: Toward the End of Completion Pancreatectomy
Markus W. Büchler, Markus Wagner, Bruno M. Schmied, Waldemar Uhl, Helmut Friess, and Kaspar Z'graggen
Arch Surg. 2003;138(12):1310-1314.
ABSTRACT
| FULL TEXT
|
